Evidence-Based Complementary and Alternative Medicine / 2019 / Article / Tab 2

Review Article

Efficacy of Danshen Class Injection in the Treatment of Acute Cerebral Infarction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

Table 2

Results of the network meta-analysis of activities of daily living function (lower left quarter) and whole blood high shear viscosity (upper right quarter).

A-1.32
(-2.37, -0.27)
-0.42
(-1.48, 0.64)
-1.55
(-2.37, -0.74)
-1.50
(-3.82, 0.81)
-1.66
(-3.11, -0.21)
-0.72
(-1.75, 0.29)
-0.57
(-2.65, 1.5)

1.63
(-5.61, 8.88)
B0.90
(-0.50, 2.31)
-0.23
(-1.43, 0.98)
-0.17
(-2.69, 2.30)
-0.34
(-2.13, 1.43)
0.60
(-0.86, 2.06)
0.75
(-1.59, 3.09)

10.83
(4.68, 16.87)
9.20
(-0.07, 18.32)
C-1.13
(-1.95, -0.33)
-1.08
(-3.15, 0.96)
-1.24
(-3.02, 0.59)
-0.30
(-1.76, 1.15)
-0.15
(-2.5, 2.2)

10.55
(7.42, 13.63)
8.92
(1.74, 16.10)
-0.28
(-6.79, 6.30)
D0.05
(-2.17, 2.24)
-0.11
(-1.75, 1.54)
0.83
(-0.46, 2.12)
0.98
(-1.25, 3.23)

9.53
(5.48, 13.60)
7.90
(0.82, 14.96)
-1.30
(-8.08, 5.61)
-1.02
(-5.92, 3.99)
E-0.16
(-2.85, 2.56)
0.77
(-1.73, 3.32)
0.92
(-2.21, 4.05)

16.53
(6.94, 26.17)
14.91
(2.97, 26.98)
5.71
(-5.55, 17.14)
5.99
(-4.17, 16.14)
7.01
(-3.34, 17.37)
F0.94
(-0.82, 2.71)
1.09
(-1.42, 3.61)

7.37
(2.35, 12.45)
5.74
(-3.14, 14.48)
-3.46
(-11.26, 4.55)
-3.18
(-9.11, 2.82)
-2.16
(-8.66, 4.27)
-9.17
(-19.95, 1.71)
G0.15
(-2.15, 2.44)

9.73
(4.00, 15.40)
8.11
(-1.05, 17.32)
-1.10
(-9.46, 7.35)
-0.82
(-7.37, 5.76)
0.21
(-6.83, 7.23)
-6.80
(-18.03, 4.38)
2.37
(-5.32, 10.08)
H

A: WM; B: Danshen injection + WM; C: Fufang Danshen injection + WM; D: Danhong injection + WM; E: Danshenchuanxiongqin injection + WM; F: Sodium Tanshinone IIA Sulfonate injection + WM; G: Salvianolate injection + WM; H: Danshen Salvianolic Acids injection + WM. The result underlined meant it had statistical significant.